Vitiligo is a long-term skin condition where certain areas lose their natural color and turn noticeably lighter than the surrounding skin. The contrast between light and darker zones can be very ...

Vitiligo significantly impacts quality of life, with psychosocial challenges more pronounced in individuals with darker skin tones. JAK inhibitors, including ruxolitinib, tofacitinib, and baricitinib, ...

Vitiligo is one of the most visually distinct skin conditions, defined by patches of depigmented skin that can appear anywhere on the body. While it’s medically harmless, its emotional impact can be ...

Vitiligo is an autoimmune disease with complex epidemiology, involving genetic, autoimmune, and environmental factors, and is associated with other autoimmune comorbidities. It presents in multiple ...